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Abstract
The permeability-enhancing effects of the two surfactants, 1-palmitoyl-2-lyso-sn-gycero-3-phosphocholine (lysoPPC) and palmitic acid
(PA), on lipid membranes that at physiological temperatures are in the gel, fluid, and liquid-ordered phases were determined using the
concentration-dependent self-quenching properties of the hydrophilic marker, calcein. Adding lysoPPC to lipid membranes in the gel-phase
induced a time-dependent calcein release curve that can be described by the sum of two exponentials, whereas PA induces a considerably
more complex release curve. However, when lysoPPC and PAwere added simultaneously in equimolar concentrations, a dramatic synergistic
permeability-enhancing effect was observed. In contrast, when both lysoPPC and PA are added to liposomal membranes that are in the fluid
or liquid-ordered phases, no effect on the transmembrane permeation of calcein was observed. D 2002 Elsevier Science B.V. All rights
reserved.
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1. Introduction
The lipid bilayer part of biological membranes is com-
posed of a large variety of different types of phospholipids,
sphingolipids, and cholesterol [1–3]. In addition, small con-
centrations of water-soluble single chain surfactants, e.g.
lysophospholipids and fatty acids (FA) are found in the
lipid membrane. The transmembrane barrier properties of
the lipid membrane are of key interest in drug research in
relation to penetration and permeation of drugs across cell
membranes [4]. For example, the permeation and transport
of new macromolecular drugs as well as small molecular
drugs across cell membranes are of crucial importance for
the ability of the drugs to reach their intracellular target sites
[4]. The major determinants of the transmembrane perme-
ability are the microscopic and macroscopic phase behavior
of the lipid membrane, which is affected by the membrane
composition and external thermodynamic conditions such as
temperature, degree of hydration, and ionic strength [5,6]. It
is, however, possible to enhance the transmembrane perme-
ability of the lipid membranes by adding surfactants in the
vicinity of the membrane and thereby increase the transport
of drugs across the membrane. FA and in particular lyso-
phosphatidylcholines (lysoPC), which can be produced by
enzymatic hydrolysis of phosphatidylcholine, are examples
of surfactants that can act to lower the passive transmem-
brane barrier properties of biological membranes [7]. Sev-
eral studies have shown that the incorporation of small
concentrations of lysoPCs or FAs into red blood cells or
well-defined vesicle membranes enhances the transmem-
brane permeability [8–15]. However, only a limited number
of studies have in a systematic way dealt with the combined
effects of the simultaneous incorporation of lysoPC and FA
on the physical properties of lipid membranes [9].
Exogenously added lysoPCs are preferentially localized
in the outside monolayer of cellular or vesicular membranes,
and movement of lysoPCs across the lipid membrane (flip-
flop) is extremely slow as compared to the flip-flop of FAs
[16–18]. Incorporation of lysoPCs or FAs into the lipid
membrane can lead to the formation of small-scale phase
separated structures, and it has been suggested that the
observed increase in the transmembrane permeability is
intimately related to the formation of a heterogeneous local
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membrane structure composed of coexisting small-scale
lipid structures with leaky boundaries [4]. The disruptive
and permeability-enhancing properties of lysoPCs and FAs
depend to some extent on the length and degree of saturation
of the attached single hydrocarbon chain [7]. This can be
understood in terms of the nonbilayer forming molecular
shape of, e.g. lysoPCs, which effectively can be described by
the inherent imbalance between volume and cross-sectional
area of the polar head-group region and the nonpolar hydro-
carbon chain region. The presence of other lipid components
that have a molecular shape opposite to that of lysoPC, for
example FA and cholesterol, can counteract the lipid mem-
brane destabilizing effects of lysoPCs [19–21].
In the present study, we have investigated the permeability
enhancing effect of 1-palmitoyl-2-lyso-sn-gycero-3-phos-
phocholine (lysoPPC) and palmitic acid (PA) on membranes
that at physiological temperatures are in the solid-ordered
(gel), liquid-disordered (fluid), and liquid-ordered phases,
using the self-quenching properties of a hydrophilic fluores-
cent calcein marker. The di-ether-1,2-SPC phospholipids
(1,2-O-distearoyl-sn-glycero-3-phosphocholine) composing
the gel (solid-ordered) phase are characterized by conforma-
tionally ordered acyl chains and a low lateral mobility of the
lipids in the membrane. The fluid-phase membranes were
made of SOPC phospholipids (1-steroyl-2-oleyl-sn-glycero-
3-phosphocholine) having an unsaturated hydrocarbon chain
in the sn-2 position. The SOPC lipids in the fluid-phase
membranes have a high degree of lateral mobility and the
hydrocarbon chains are much more flexible and confor-
mationally disordered than the chains in the gel-phase di-
ether-1,2-SPC membranes. Finally, the membranes in the
liquid-ordered phase were made of a mixture of SOPC and
cholesterol. The SOPC lipids in these membranes have a high
degree of lateral mobility but the hydrocarbon chains are
conformationally ordered by the presence of cholesterol [5].
2. Materials and methods
2.1. Materials
The lipids, 1,2-O-distearoyl-sn-glycero-3-phosphocho-
line (di-ether-1,2-SPC), 1-steroyl-2-oleyl-sn-glycero-3-phos-
phocholine (SOPC), cholesterol, 1-palmitoyl-2-hydroxy-sn-
glycero-3-phosphocholine (lysoPPC), and PA were pur-
chased from Avanti Polar Lipids (Alabaster, AL). Calcein
(2,4-bis-(N,NV-di(carboxymethyl)aminomethyl)fluorescin)
was purchased from ICN Biochemicals (Costa Mesa, CA)
and Sephadex G-50 was purchased from Pharmacia
(Uppsala, Sweden). All chemicals were used without further
purification.
2.2. Preparation of liposomes containing entrapped calcein
Multilamellar (MLV) liposomes were made by dispersing
a weight amount of lipid in a HEPES buffer solution
(10 mM HEPES, 110 mM KCl, 1 mM NaN3, 30 AM CaCl2,
10 AM NaEDTA, pH 7.5) containing the water-soluble
marker, calcein, in a self-quenching concentration (20
mM). Calcein were dissolved in water and pH were adjusted
with NaOH to pH=7.5 prior to adding the calcein solution to
the 10 mM HEPES buffer. The lipid suspension was kept at
a temperature 10 jC above the main phase transition
temperature of di-ether-1,2-SPC (Tm=55.5 jC) for 1 h in
order to ensure complete hydration. During this period, the
lipid suspension was vortexed every 15 min. The multi-
lamellar liposomes were extruded 10 times through two
stacked 100-nm pore size polycarbonate filters forming
unilamellar liposomes (LUV) with a narrow size distribution
[22]. Untrapped calcein was removed from the liposome
suspension by gel filtration through a column packed with
Sephadex G-50 using a HEPES buffer solution (10 mM
HEPES, 150 mM KCl, 1 mM NaN3, 30 AM CaCl2, 10 AM
NaEDTA, pH 7.5) as eluent. The lipid concentration was
determined by HPLC, and the samples were diluted with
eluent to a final lipid concentration of 20 AM. This dilution
ensured a calcein concentration of less than 1 AM after
release of all the calcein from the liposomes. Our standard
curve for calcein showed that the fluorescence intensity of
calcein displays a linear dependency in concentrations up to
1 AM. The high calcein concentration (20 mM) of the
encapsulated calcein led to self-quenching of its fluores-
cence, resulting in low background fluorescence intensity of
the liposomes. Control experiments showed that the calcein
fluorescence was unaffected by the presence of PA and
lysoPPC at concentrations used in the experiments.
2.3. Calcein release measurements
The permeability enhancing effects of lysoPPC and PA
as well as equimolar mixtures of lysoPPC and PA were
determined by measuring the amount of entrapped calcein
that was released from the liposomes as a function of time, t.
LysoPPC was added to the liposome suspension directly
from a 1 mM aqueous stock solution containing 20%
methanol, and PA was added from a 5 mM 100% methanol
stock solution. The 1 mM lysoPPC and 1 mM PA equimolar
mixture was added from a 20% methanol stock solution.
The final concentration of methanol in the experimental
samples did not exceed 1% (v/v). Control experiments
showed that methanol by itself did not cause any significant
calcein release. The fluorescence intensity of calcein in the
samples was measured at excitation wavelength of 492 nm
and emission wavelength of 520 nm using a SLM DMX-
1100 spectrofluorometer. The 90j static light-scattering,
which reflects morphological changes of the lipid system
[23,24], was measured simultaneously with the fluorescence
intensity.
Each liposome sample was equilibrated at 39 jC for 10
min before the background fluorescence intensity (IB) was
measured. The surfactants were added to the liposomes
under vigorously stirring to obtain final global concentra-
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tions of 2.5, 5.0, or 10.0 AM corresponding to 12.5, 25.0,
and 50.0 mol% of the di-ether-1,2-SPC concentration. It is
expected that lysoPPC and PA, which are added in concen-
trations above their cmc, are incorporated rapidly into the
bilayer [7]. The enhanced permeability of the lipid mem-
branes was monitored by the time-dependent fluorescence
intensity (IF(t)) increase, which results from diluting of the
encapsulated self-quenching calcein into the surrounding
buffer. Total fluorescence (Itot), corresponding to release of
all the entrapped calcein from the liposomes, was measured
after complete solubilization of the liposomal membranes by
adding Triton X-100 to the samples. The time-dependent
release of calcein from the di-ether-1,2-SPC liposomes was
calculated as: %R(t)=100 (IF(t)IB)/(ItotIB).
The experiments on the di-ether-1,2-SPC gel-phase lip-
osomes were repeated at least three times and the standard
deviations are shown on the release curves. Experiments on
the di-ether-1,2-SPC liquid-ordered state liposomes with 40
mol% cholesterol and on the fluid-phase SOPC liposomes
were repeated twice.
3. Results and discussion
Typical measurements of the time-dependent calcein
permeation through di-ether-1,2-SPC lipid membranes in
the gel-phase, monitored by the fluorescence intensity
increase of calcein released from the interior of the lip-
osomes into the aqueous bulk are shown in Fig. 1 (solid
lines). Also shown is the 90j static light scattering, which
reflects morphological changes in the lipid system (dashed
lines). The solid line in Fig. 1A shows that lysoPPC added
to the calcein containing di-ether-1,2-SPC liposomes at time
zero results in a fast initial increase in the permeation of
calcein across the liposomal membranes. This is clearly seen
as an abrupt increase in the fluorescence intensity, IF(t),
compared to the background level, IB. The initial fast
increase is followed by a second stage where the trans-
membrane permeability decreases and the release curve
reaches a level of saturation. The total fluorescence inten-
sity, Itot, which corresponds to the release of all the entrap-
ped calcein, was determined by complete solubilization of
the liposomes by Triton X-100. The time course of the
increase in the transmembrane permeability induced by PA
is shown in Fig. 1B. The initial increase in the transmem-
brane permeability induced by PA is slower than that
induced by lysoPPC. However, the transmembrane perme-
ability slowly increases and after about 600 s, the total
amount of calcein released by PA is actually higher than the
total amount released by lysoPPC.
In order to investigate the combined effect of lysoPPC
and PA, the two surfactants were added simultaneously from
an equimolar mixture to the calcein containing gel-phase di-
ether-1,2-SPC liposomes. Fig. 1C shows that the simulta-
neous addition of lysoPPC and PA induces a fast and large
increase in the transmembrane permeability, resulting in the
release of almost all the encapsulated calcein. The data in
Fig. 1C strongly indicates that PA and lysoPPC act in a
synergistic fashion to increase the permeability of the gel-
phase di-ether-1,2-SPC membranes. A similar fast increase
in the transmembrane permeability was observed when the
liposomes were added to a buffer solution containing the
same global concentration of the two surfactants. Therefore,
it can be excluded that the unexpected fast increase is a
response to high local concentrations of surfactants in the
immediate surroundings of a minor population of the di-
ether-1,2-SPC liposomes.
The synergistic effect induced by PA and lysoPPC was
studied systematically by adding increasing concentrations
of lysoPPC, PA, and equimolar mixtures of the two surfac-
Fig. 1. Calcein released from 20 AM di-ether-1,2-SPC liposomes in HEPES
buffer at 39 jC, induced by adding (A) 10 AM lysoPPC, (B) 10 AM PA, and
(C) 10 AM mixture of PA and lysoPPC (1:1). IB is the background
fluorescence intensity from self-quenched calcein loaded in the di-ether-
1,2-SPC liposomes, IF(t) is the fluorescence intensity versus time after
adding the surfactant, and Itot is the total fluorescence intensity after adding
triton X-100. The dashed lines in (A) through (C) represent the 90j static
light scattering.
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tants to gel-phase di-ether-1,2-SPC liposomes, measuring
the transmembrane permeability. Fig. 2A shows the time-
dependent calcein release, R(t), induced by adding 2.5 AM
lysoPPC, PA, and an 2.5 AM equimolar mixture to 20 AM
di-ether-1,2-SPC liposomes. LysoPPC and PA added sepa-
rately induce a slow increase in the transmembrane perme-
ability, and after 20 min, only 4% to 5% of the encapsulated
calcein was released from the di-ether-1,2-SPC liposomes.
However, when PA and lysoPPC were added simultane-
ously, a fast instantaneous increase in the transmembrane
permeability was observed, leading to release of around
24% of the encapsulated calcein. Fig. 2B,C shows the time-
dependent release of calcein from the liposomes after
increasing the concentrations of added surfactants to 5 and
10 AM, corresponding to 25 and 50 mol%, respectively, of
the di-ether-1,2-SPC lipid concentration. The simultaneous
addition of increasing amounts of the equimolar mixture of
PA and lysoPPC induces the release of around 47% and
92% of the encapsulated calcein in 20 min, respectively. In
contrast, the addition of the same concentrations of lysoPPC
result in the release of only around 10% and 20%, whereas
PA induces the release of approximately 18% and 27% of
the encapsulated calcein after 20 min. It is interesting to
observe that significantly different time-dependent release
curves are induced by lysoPPC as compared to those of PA,
suggesting that different mechanisms are involved in the
permeability increasing effect mediated by PA and lysoPPC.
The increase in transmembrane permeability induced by
lysoPPC can be described by a sum of two exponentials
with fast and slow components. The fast component is likely
to be dominated by the transfer of lysoPPC from the
aqueous bulk into the outer monolayer of the lipid mem-
branes, and by lateral diffusion and rearrangement of
lysoPPC in the outer monolayer of the lipid membranes
[25]. This might lead to the formation of nonequilibrium
small-scale phase separated lipid structures similar to those
that earlier have been reported in lipid membrane mixtures
[6]. At the same time, transient nanometer-size defects could
form whereby the entrapped calcein can leak through the
membrane [6,25–27]. The second slow component is
thought to be dominated by the slow rate of lysoPPC
transfer across the lipid bilayer from the outer to the inner
monolayer, thereby reducing the packing constrains and
leading to resealing of the membranes [16–18]. Fig. 2C
shows that addition of the same concentrations of PA to the
di-ether-1,2-SPC liposomes induces a considerably more
complex release curve. The difference in the permeability-
enhancing effects probably reflects differences in the
kinetics of the incorporation of the FAs and lysoPCs in
the membranes [7]. However, when PA is added simulta-
neously with lysoPPC, an unexpected synergistic effect is
observed as described above. The general shape of the
release curves for the equimolar mixture is similar to that
induced by lysoPPC, although the instantaneous increase is
much more dramatic. The synergistic effect of PA and
lysoPPC on the transmembrane permeability is further
demonstrated in Fig. 3, which in a quantitative way shows
the percentage of calcein release 20 min after adding
increasing concentrations of the surfactants.
It is clear from the data in Figs. 1 and 2 that the barrier
properties of the gel-phase di-ether-1,2-SPC lipid mem-
branes are reestablished quite fast after addition of the
surfactants. Fig. 4 shows how consecutive additions of
surfactants to the same population of di-ether-1,2-SPC lip-
osomes induce a stepwise increase in the transmembrane
permeability followed by a resealing of the membranes.
However, the second addition of the 2.5 AM equimolar
Fig. 2. Percent calcein release from di-ether-1,2-SPC liposomes versus time
after adding PA (diamonds), lysoPPC (triangles), and an equimolar mixture
of PA and lysoPPC (squares) in 2.5 AM (A), 5.0 AM (B), and 10 AM (C)
concentrations, corresponding to 12.5, 25 and 50 mol% of the total di-ether-
1,2-SPC lipid concentration. Each measurement was repeated at least three
times and the error bars represent the S.D. of the measurements.
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mixture of PA and lysoPPC leads to a much larger increase
in the transmembrane permeability as compared to the initial
addition of the 2.5 AM equimolar mixture of lysoPPC and
PA. This indicates that the incorporation of PA and lysoPPC
from the first addition has changed the physical properties
of the membranes, thereby facilitating the further incorpo-
ration of lysoPCs and FAs. The third addition induces an
increase in the transmembrane permeability that leads to the
release of nearly all the calcein remaining in the interior of
the liposomes.
The effect of adding PA and lysoPPC on the trans-
membrane permeability of the di-ether-1,2-SPC lipid mem-
branes was further investigated in experiments where di-
ether-1,2-SPC liposomes were preincubated with 2.5 AM PA
prior to adding 10 AM lysoPPC. The dashed line in Fig. 5
shows that 10 AM lysoPPC induces a fast increase in the
transmembrane permeability of the di-ether-1,2-SPC lipid
membranes. Conversely, adding 10 AM PA to di-ether-1,2-
SPC liposomes preincubated with 2.5 AM lysoPPC induces
a much smaller increase in the transmembrane permeability,
as shown by the solid line in Fig. 5. This indicates that the
permeability-enhancing effect of lysoPPC is increased by
the presence of small concentrations of FAs. This effect can
possibly be ascribed to the ability of FA to perturb the dense
head-group region of the gel-phase membranes, thereby
making space for fast local incorporation of the more bulky
lysoPCs [28–30]. The results reported so far demonstrate
that PA and lysoPPC can act to enhance the transmembrane
permeability of gel-phase membranes. Interestingly, the
results show that lysoPPC and PA can act in a synergistic
fashion to induce an unexpected fast increase in the trans-
membrane permeability of gel-phase membranes.
We have furthermore investigated the permeability-
enhancing properties of lysoPPC and PA on membranes in
both the fluid- and liquid-ordered phases. The physical
properties of these fluid-phase membranes are considerably
different than the physical properties of gel-phase mem-
branes [31]. Fig. 6A shows the fluorescence of calcein
encapsulated in fluid-phase SOPC liposomes versus time
(solid line). Also, the 90j static light scattering from the
liposomes versus time are shown (dashed line). Equimolar
mixtures of lysoPPC and PA (20 AM) were added as
indicated by the arrows. The added PA and lysoPPC have
no effect on the transmembrane permeability of the fluid-
phase SOPC membranes. This is in contrast to the dramatic
permeability-enhancing effect observed on di-ether-1,2-SPC
membranes in the gel phase. However, a pronounced
increase in the static light scattering from the fluid-phase
liposomes is observed, indicating a change in the overall
morphology of the liposomes. This is possibly due to
aggregation or fusion of the liposomes induced by PA and
lysoPPC [23]. Experiments with di-ether-1,2-SPC lipo-
somes incorporated with 40 mol% cholesterol, which is in
the liquid-ordered phase [32], yield similar results, although
there were no changes in the light scattering (Fig. 6B). The
relationship between the permeability-enhancing effect of in
Fig. 3. Percent calcein release after 20 min as a function of increasing
concentrations of lysoPPC (triangles), PA (diamonds), and an equimolar
mixture of lysoPPC and PA (squares), to 20 AM di-ether-1,2-SPC liposomes
at 39 jC.
Fig. 4. Percent calcein release versus time. Equimolar mixtures of PA and
lysoPPC were added stepwise to a population of 20 AM di-ether-1,2-SPC
liposomes at 39 jC.
Fig. 5. Addition of 10 AM lysoPPC to 20 AM di-ether-1,2-SPC liposomes
preincubated with 2.5 AM PA (dashed line) and addition of 10 AM PA to
20 AM di-ether-1,2-SPC liposomes preincubated with 2.5 AM lysoPPC
(solid line).
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particular lysoPCs and the composition and physical state of
lipid membranes has previously been investigated using red
blood cells [15,33,34]. These experiments showed that the
permeability-enhancing effect of lysoPCs on red blood cells
was also drastically increased when the red blood cells were
cooled down from a fluid state at physiological temperatures
to a gel-like state close to 0–5 jC [15]. The difference in the
permeability-enhancing effect of the surfactants on mem-
branes in the gel- and fluid-phases can possibly be explained
in terms the lateral diffusion of the lipids, which for gel-
phase membranes is at least two orders of magnitude smaller
than in the fluid-phase [27]. This probably means that the
membranes in the fluid- and liquid-ordered phases reseal on
a much faster time scale than the membranes in the gel
phase.
4. Conclusion
The permeability-enhancing effect of lysoPPC and PA on
membranes in the gel, fluid- and liquid-ordered phases were
studied using the self-quenching properties of the hydro-
philic fluorescent marker, calcein. The experimental results
demonstrate that lysoPPC and PA act in a synergistic
fashion to enhance the transmembrane permeability of gel-
phase membranes. Furthermore, the data revealed that the
time-dependent release curves induced by PA were signifi-
cantly different from the release curves induced by lysoPPC,
suggesting that the mechanisms behind the increased trans-
membrane permeability are different for the two surfactants.
In contrast to the dramatic permeability-enhancing effect of
lysoPPC and PA on gel-phase membranes, no changes in the
transmembrane permeability of fluid- and liquid-ordered
phase membranes were observed. However, a significant
increase in the 90j static light scattering from liposomes in
the fluid state was observed when lysoPPC and FA were
added, possibly due to aggregation or fusion of the lip-
osomes. Apparently, the results of the present study indi-
cate that lysoPCs and free FAs cannot be expected to
increase the permeability of the lipid bilayer part of bio-
logical membranes, which often is assumed to be in the
fluid- or liquid-ordered phase at physiological temperatures
[4]. If, however, small domains in the biological membrane
are composed of lipids that are in the gel-phase, lysoPCs
and free FAs are likely to decrease the barrier properties of
those local membrane regions, resulting in an increase in
the drug permeation across the target membrane. Further-
more, the synergistic permeability-enhancing effect of
lysoPC and FA can advantageously be used to trigger a
rapid drug release from drug transporting vehicles com-
posed of gel-phase lipid membranes.
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